BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6970027)

  • 1. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
    Zółtowska A; Skokowski J; Mlekodaj S; Boj E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocompetence in lung cancer patients: analysis of serological and cellular parameters.
    Pierri I; Rogna S; Tavano A; Setti M; Scudeletti M; Ratto G; Motta G; Indiveri F
    Cancer Detect Prev; 1988; 13(2):95-101. PubMed ID: 3242825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in T cell population in patients with bronchogenic carcinoma.
    Shirakusa T; Shigematsu N; Yoshida T; Saito R; Katayama N; Inokuchi K
    J Thorac Cardiovasc Surg; 1978 Aug; 76(2):262-5. PubMed ID: 308122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E rosettes in the uranium miners with lung cancer.
    Kudrna K; Andrlíková J; Smíd A; Stipl Z
    Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
    Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA
    Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of T lymphocytes in resected lung tissue in primary bronchial cancer].
    Grubek-Jaworska H; Olechnowicz H; Szymańska
    Pneumonol Pol; 1984 Mar; 52(3):105-10. PubMed ID: 6610173
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lymphocytes subpopulation in cancer's patients. Relationship with primitive anatomical location, histological type and clinical stage (author's transl)].
    Saiz Garcia F; Rodriguez Valverde V
    Bull Cancer; 1981; 68(1):32-9. PubMed ID: 6971668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
    Ito N; Nakamura H; Tanaka Y; Ohgi S
    Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Active specific immunotherapy in patients with lung cancer following tumor removal].
    Mosienko MD; Dorfman MV; Romashko NI
    Vopr Onkol; 1987; 33(3):31-6. PubMed ID: 3494337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of lymphocytes forming "active rosettes" in lung cancer].
    Youinou P; Clavier J; Guillerm D; Miossec P; Kerbrat G
    Rev Fr Mal Respir; 1982; 10(6):409-16. PubMed ID: 7163596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of the localization on the prognostic value of E, E-active and autologous rosettes in lung, esophagus and otorhinolaryngologic cancer].
    Youinou P; Miossec P; Labat JP; Clavier J; Coatalem M; Guillerm D; Kerbrat G
    Sem Hop; 1983 Dec; 59(44):3033-7. PubMed ID: 6320389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in immunoregulatory cells in lung cancer and smoking.
    Ginns LC; Miller LG; Goldenheim PD; Goldstein G; Bria WF
    J Clin Immunol; 1982 Jul; 2(3 Suppl):90S-94S. PubMed ID: 6982280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological studies on lymphocytes in respiratory diseases. I. Studies on the subpopulation of human peripheral blood lymphocytes in respiratory diseases (author's transl)].
    Mayumi T
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):60-73. PubMed ID: 687844
    [No Abstract]   [Full Text] [Related]  

  • 17. Active T-rosette-forming cells in the peripheral blood of cancer patients.
    Kerman RH; Smith R; Stefani SS; Ezdinili EZ
    Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
    García MS; Barañao RI; Fernández O; Rumi LS
    Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.